U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06798727) titled 'Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Patients Receiving SMUP-IA-01 or Active Control' on Jan. 23.
Brief Summary: This is a follow-up study to investigate the long-term safety and explore efficacy of SMUP-IA-01, for the treatment of Knee Osteoarthritis. Subjects who participated in and completed the initial stage of the Phase II trial (NCT05182034) will be followed-up until 60 months.
Study Start Date: March 20, 2023
Study Type: INTERVENTIONAL
Condition:
Knee Osteoarthritis
Intervention:
BIOLOGICAL: SMUP-IA-01(low-dose)
A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10^6 cells/2mL)
B...